跳至主要内容
临床试验/EUCTR2007-004096-19-GB
EUCTR2007-004096-19-GB进行中(未招募)1 期

Beta Agonist Lung injury Trial - Prevention Study - BALTI Prevention

Birmingham Heartlands Hospital0 个研究点目标入组 360 人开始时间: 2008年2月21日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Provision of informed consent.
  • 2. Age >18years.
  • 3. Planned elective transthoracic oesophagectomy.
  • 4. Ability to use inhaler with spacer device.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnancy.
  • 2. Current treatment with long acting beta agonist (any formulation).
  • 3. Allergy to excipients contained in the salmeterol inhaler.
  • 4 Current treatment with non-cardioselective beta blockers (the cardioselective beta blockers atenolol, betazolol, bisoprolol and metoprolol are permitted).
  • 5. Treatment with an investigational medicinal product in the last 30 days.

研究者

发起方
Birmingham Heartlands Hospital

相似试验